Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NA-931 by Biomed Industries for Obesity: Likelihood of Approval
NA-931 is under clinical development by Biomed Industries and currently in Phase III for Obesity. According to GlobalData, Phase III...